CJC-1295 (DAC Modification)

C₁₅₂H₂₅₂N₄₄O₄₂ · 3367.97 g/mol

CJC-1295 with Drug Affinity Complex (DAC) is a synthetic analog of growth-hormone-releasing hormone (GHRH), distinguished from CJC-1295 without DAC by a covalent modification at a lysine side chain that binds serum albumin and extends circulating half-life. It is studied as a long-acting GHRH-receptor agonist for growth-hormone-axis and somatotropic-signaling research.

The source monograph lists this DAC-conjugated variant with the same backbone formula/MW and CAS (863288-34-0) already used on this catalogue's CJC-1295 (no DAC) listing — a common ambiguity in supplier literature, since the DAC linkage itself isn't reflected in either figure. Confirm exact structure and CAS against the supplier's COA before quoting either product.

Purity

On request

Quantity

Milligram, gram, or bulk quantities

Documentation

COA, HPLC, MS / LC-MS, SDS

Packaging

Bulk, non-branded, or private label

Request a Quote Request Documentation

Research Use Only · Buyer verification required

Specifications

Technical profile.

Catalog Number

PB-095

CAS Number

863288-34-0

Sequence

H-Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Glu-Gly-Gln-Asp-Ser-Ser-Gly-Arg-Pro-Arg-Leu-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-NH2

Molecular Formula

C₁₅₂H₂₅₂N₄₄O₄₂

Molecular Weight

3367.97 g/mol

Purity (HPLC)

Available specifications confirmed with quotation

Appearance

White to off-white lyophilized powder

Vial Size

Confirmed with quotation

Storage

−20 °C, sealed, desiccated, protected from light

Reconstitution

Bacteriostatic water

Classification

Research Use Only

Documentation & Quality

What documentation may be available for CJC-1295 (DAC Modification).

CJC-1295 (DAC Modification)·PB-095

Certificate of Analysis (COA)

Manufacturing partner or independent summary of identity, purity, and other release testing for a batch.